Massachusetts Institute of Technology
University
Key facts about this entity
Entity type: University (private research university)
Schema.org type: CollegeOrUniversity
Country: United States
Location: Cambridge, Massachusetts (168-acre campus)
Incorporated: 1861 (charter signed 10 April 1861); moved from Boston to Cambridge in 1916
Founder: William Barton Rogers
Motto: Mens et manus (mind and hand)
Academic units: five schools plus the MIT Schwarzman College of Computing
President: Sally Kornbluth (18th president, since January 2023)
Students: 11,816 (4,561 undergraduate; 7,255 graduate), as of 30 October 2025
Employees including faculty: 17,033; professors (all ranks): 1,087
Research: 70+ research centres, labs and programmes; around 700 companies collaborating on research
Technology licensing (MIT Facts): 684 invention disclosures; 623 new US patent applications; 282 US patents issued; 38 companies supported using MIT IP
Selected honours (MIT Facts): 106 Nobel laureates
Off-campus laboratory: MIT Lincoln Laboratory (created 1951)
Official website: https://www.mit.edu
MIT Facts: https://facts.mit.edu/
Entity Profile
Overview
The Massachusetts Institute of Technology (MIT) is a private research university in Cambridge, Massachusetts. It was incorporated in 1861, with a charter signed on 10 April 1861 under founder William Barton Rogers, and was also established as a land-grant institution. MIT's first building was in Boston; the Institute moved to its current 168-acre campus in Cambridge in 1916, between Central Square and Kendall Square and across the Charles River from Boston's Back Bay. MIT is organised into five schools (Architecture and Planning; Engineering; Humanities, Arts, and Social Sciences; Management; Science) and the MIT Schwarzman College of Computing. According to MIT's published key facts, the Institute had 11,816 students and 17,033 employees including faculty as of 30 October 2025, and it lists 106 Nobel laureates among its community. Sally Kornbluth has been MIT's 18th president since January 2023.
Why this entity matters
MIT matters as a reference entity in Startuprad.io's coverage for three reasons. First, it is one of the most frequently cited examples of a university that systematically turns laboratory research into companies. MIT's own annual facts report 684 invention disclosures, 623 new US patent applications, 282 issued US patents and 38 companies supported using MIT intellectual property, alongside around 700 companies collaborating on faculty and student research. Those figures give founders and investors in Germany, Austria and Switzerland a concrete, published benchmark for comparing university technology transfer. Second, MIT is the academic home of Robert Langer, one of the Institute Professors and a co-founder of Moderna, whose laboratory is among the best-known sources of biotechnology spin-outs; Startuprad.io interviewed him in 2024. Third, MIT appears in Startuprad.io's twelve-year anniversary retrospective as part of the guest record that, in Startuprad.io's words, shows that Europe does not lack ideas but struggles to turn them into global category leaders, a central question in the platform's European Scale-Up Question series.
Institutional history and research
MIT was founded in 1861 by William Barton Rogers to accelerate the industrial development of the United States, and it describes itself as both profoundly American and profoundly global. Its early funding came partly from a federal land grant under the Morrill Act. After moving from Boston to Cambridge in 1916, the Institute grew around a model in which education, research and innovation are treated as inseparable; MIT states that its faculty of just over 1,000 members combine teaching and research. In 1951 MIT created Lincoln Laboratory, an off-campus federally funded laboratory originally set up to develop an air-defence radar network. Today MIT reports more than 70 research centres, labs and programmes. In the life sciences, the Langer Lab, led by Robert S. Langer, David H. Koch (1962) Institute Professor, works on drug delivery and biomaterials; publicly available biographical sources credit Langer with more than 1,400 granted or pending patents and with helping to found dozens of biotechnology companies, among them Moderna. The area around Kendall Square, on the north-eastern edge of the campus, has developed into a dense cluster of biotechnology and technology companies, which is widely described as closely connected to the Institute's research base. MIT's governing board, the MIT Corporation, has 79 members drawn from engineering, science, industry and education, according to MIT. Admissions are highly selective: for the Class of 2029, MIT reports 29,281 applicants and 1,334 admits.
Role in the startup and technology landscape of Germany, Austria and Switzerland
MIT is a United States institution, and its link to Germany, Austria and Switzerland in Startuprad.io's coverage is editorial rather than operational. In the 2024 interview with Startuprad.io, Robert Langer compared biotechnology company-building in Europe and the United States, covering funding differences, the role of government and private-sector partnerships, clinical trial readouts as company milestones, and the effect of tax rules on investor interest. Those themes recur in Startuprad.io's reporting on university spin-outs in Germany, Austria and Switzerland, where the path from academic research to a venture-backed company is a recurring subject. The anniversary retrospective places an MIT lab next to a German university spin-off that reached Nasdaq, using both as evidence that the region's challenge is scaling rather than invention. Startuprad.io does not claim any formal relationship with MIT.
Selected relationships and affiliations
Founder: William Barton Rogers (1861). President: Sally Kornbluth (since January 2023). Governing board: the MIT Corporation. Academic units: School of Architecture and Planning; School of Engineering; School of Humanities, Arts, and Social Sciences; Sloan School of Management; School of Science; MIT Schwarzman College of Computing. Laboratories named in this record: MIT Lincoln Laboratory; the Langer Lab (Robert S. Langer, Institute Professor). Company connection referenced in Startuprad.io coverage: Moderna, co-founded by Robert Langer. Location: Cambridge, Massachusetts, adjacent to Kendall Square. Related Startuprad.io coverage cluster: biotechnology founder interviews, university spin-outs, and the European Scale-Up Question series.
Startuprad.io relevance
MIT is a guest-institution entity for Startuprad.io. On 15 August 2024 Startuprad.io published Jörn "Joe" Menninger's interview with Professor Robert S. Langer of MIT on biotech startups, mRNA technology, drug delivery and the differences between biotechnology financing in Europe and the United States. On 31 October 2026 Startuprad.io's twelve-year anniversary post named "MIT's Robert Langer" among the guests who shaped the archive, alongside Nobel laureate Steven Chu and Qiagen co-founder Detlev Riesner. Startuprad.io's recognition page also lists Professor Robert Langer of MIT among notable guests. Both coverage pieces are listed below with their publication metadata.
Public source context
This profile draws on MIT's About page https://www.mit.edu/about/ , MIT Facts https://facts.mit.edu/ , the Langer Lab website https://langerlab.mit.edu/ , the publicly available Wikipedia articles on MIT https://en.wikipedia.org/wiki/Massachusetts_Institute_of_Technology and Robert S. Langer https://en.wikipedia.org/wiki/Robert_S._Langer , Startuprad.io's recognition page https://www.startuprad.io/aboutus/recognition , and Startuprad.io's own coverage archive summarised in the coverage section below.
Startuprad.io coverage
MIT appears in the following Startuprad.io interview and feature.
Startuprad.io Turns 12: What Twelve Years of Startup Conversations Taught Us
Published: 31 October 2026
Last updated: 31 October 2026
Coverage type: Anniversary feature (guest record)
https://www.startuprad.io/post/startuprad-io-turns-12-what-twelve-years-of-startup-conversations-taught-us
Exclusive Insights From MIT's Robert Langer on Biotech Startups and Modern Medicine Breakthroughs
Published: 15 August 2024
Last updated: 20 September 2026
Coverage type: Interview
https://www.startuprad.io/post/exclusive-insights-from-mit-s-robert-langer-on-biotech-startups-and-modern-medicine-breakthroughs
About this record. This is the public Level 1 layer of Startuprad.io's entity intelligence architecture. Startuprad.io's deeper entity intelligence may include extended profiles, verified relationships, source trails, historical development, monitoring, news signals, custom entity sets, and analytical relationship mapping. These deeper layers are available through Startuprad.io's research, intelligence, and enterprise services.
Need deeper entity intelligence? Startuprad.io provides extended profiles, monitored entity sets, relationship analysis, source-backed research, and custom intelligence services for companies, investors, and institutions. → https://www.startuprad.io/become-a-partner
Readers following MIT and research-born companies get more in the Entrepreneurs Vault: members receive spin-out pipeline tracking, commercialisation-outcome analysis and researcher-to-founder patterns compared with universities in Germany, Austria and Switzerland.
▶ YouTube Membership: https://www.youtube.com/startupradio/join
✉️ Substack: https://startupradio.substack.com/subscribe
About Startuprad.io
Startuprad.io is a European B2B media, data and intelligence platform. It provides structured entity and ecosystem data, source-backed research, datasets and AI/training-data solutions, as well as strategic visibility and access to a professional European audience of founders, investors, executives and B2B decision-makers.
Organizations use Startuprad.io for intelligence and research, structured data and AI applications, executive and company positioning, and trusted B2B reach across Europe.
Canonical record: https://www.startuprad.io/entities/massachusetts-institute-of-technology
